Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04685772 · ClinicalTrials.gov registry record
Assessment of the Efficacy of Medrol Dose Pack for Acute Post-Concussive Headaches
A clinical trial of Headache and Post-Concussion Syndrome, sponsored by Northwell Health.
- Recruiting
- Registry status
- 25
- Enrollment target
- 1
- Study location
NCT04685772 is a study of Headache and Post-Concussion Syndrome that is actively recruiting participants, run by Northwell Health. The registered enrollment target is 25 participants, below the 155-participant average among 35 other Headache trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04685772, a study of Headache and Post-Concussion Syndrome, is actively recruiting participants, sponsored by Northwell Health.
- RECRUITING
- Registry status
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
This novel pilot project will assess the effectiveness of corticosteroids in treatment of acute post-concussion headache. The investigators hypothesize that the use of corticosteroids will cause significant headache reduction in frequency and/or intensity than individuals who undergo the current standard of care. Additionally, the investigators hypothesize that corticosteroid use will lead to a reduction in other somatic symptoms including vestibular symptoms, leading to quicker return to school, work, and/or ability to play sports.
Conditions Studied
Interventions
- DRUG Methylprednisolone
Study Locations (1)
New York
- Northwell Health - North Shore University Hospital - Manhasset
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2021-04-01 |
| Est. Completion | 2026-12-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04685772
The ClinicalTrials.gov registry entry for NCT04685772 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 155-participant average among 35 other Headache trials with a reported enrollment target (84% lower). The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Headache appearing as the primary indexed condition, and to 1 intervention - of which Methylprednisolone is the first listed.
NCT04685772 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT04685772 about?
NCT04685772 is a clinical study titled "Assessment of the Efficacy of Medrol Dose Pack for Acute Post-Concussive Headaches". This novel pilot project will assess the effectiveness of corticosteroids in treatment of acute post-concussion headache. The investigators hypothesize that the use of corticosteroids will cause significant headache reduction in frequency and/or intensity than individuals who undergo the current sta...
What is the current status of trial NCT04685772?
This trial is currently recruiting. The enrollment target is 25 participants. The study started on 2021-04-01. Estimated completion is 2026-12-01.
What conditions does trial NCT04685772 study?
This clinical trial studies the following conditions: Headache, Post-Concussion Syndrome.
What interventions are being tested in trial NCT04685772?
The interventions under investigation include: Methylprednisolone (DRUG).
Who is sponsoring clinical trial NCT04685772?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04685772 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Headache
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Concussion Recovery and Support Program
RECRUITING · NA
-
Personalized Brain Stimulation to Treat Chronic Concussive Symptoms
RECRUITING · Phase 2
-
Lidocaine Infusion Treatment for Subarachnoid Hemorrhage Headaches
RECRUITING
-
Puberty, Testosterone, and Brain Development
RECRUITING
-
Responding With Evidence and Access for Childhood Headaches
RECRUITING · NA
-
Determining the Utility of a Behavioral Intervention in Chronic Migraine
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.